Literature DB >> 19538994

The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice.

Yasuyuki Akiyama1, Takeshi Mori, Yoshiki Katayama, Takuro Niidome.   

Abstract

Gold nanorods have strong absorbance in the near infrared region, which penetrates deeply into tissues, where the absorbed light energy is converted into heat. Therefore, gold nanorods are expected to act as an effective contrast agent for in vivo bioimaging and as a thermal converter for photothermal therapy. We grafted various amounts of polyethylene glycol (PEG) onto the surface of gold nanorods and investigated the effects of grafting level and injection dose on the biodistribution in the tumor-bearing mice after intravenous injection and enhanced permeability and retention (EPR). Higher PEG grafting levels were advantageous for reticuloendothelial system (RES) avoidance and for suppression of aggregation of the gold nanorods in the circulation. Modification with a PEG:gold molar ratio of 1.5 was sufficient to show both prolonged circulation and the EPR effect. When the injection dose was increased above 19.5 microg of gold, the RES uptake in the liver was saturated and surplus gold nanorods were distributed to other tissues, especially the spleen and the tumor. The results of this study will provide an important basis for the development of cancer therapies mediated by the photothermal effect of gold nanorods.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538994     DOI: 10.1016/j.jconrel.2009.06.006

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  37 in total

1.  Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages.

Authors:  M M Janát-Amsbury; A Ray; C M Peterson; H Ghandehari
Journal:  Eur J Pharm Biopharm       Date:  2010-11-18       Impact factor: 5.571

2.  Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo.

Authors:  Rizia Bardhan; Wenxue Chen; Marc Bartels; Carlos Perez-Torres; Maria F Botero; Robin Ward McAninch; Alejandro Contreras; Rachel Schiff; Robia G Pautler; Naomi J Halas; Amit Joshi
Journal:  Nano Lett       Date:  2010-11-22       Impact factor: 11.189

3.  Are high drug loading nanoparticles the next step forward for chemotherapy?

Authors:  Joseph Della Rocca; Demin Liu; Wenbin Lin
Journal:  Nanomedicine (Lond)       Date:  2012-03       Impact factor: 5.307

Review 4.  PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution.

Authors:  Zahid Hussain; Shahzeb Khan; Muhammad Imran; Muhammad Sohail; Syed Wadood Ali Shah; Marcel de Matas
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

Review 5.  Chemical basis of interactions between engineered nanoparticles and biological systems.

Authors:  Qingxin Mu; Guibin Jiang; Lingxin Chen; Hongyu Zhou; Denis Fourches; Alexander Tropsha; Bing Yan
Journal:  Chem Rev       Date:  2014-06-13       Impact factor: 60.622

6.  Translational considerations for cancer nanomedicine.

Authors:  Stephan T Stern; Jennifer B Hall; Lee L Yu; Laura J Wood; Giulio F Paciotti; Lawrence Tamarkin; Stephen E Long; Scott E McNeil
Journal:  J Control Release       Date:  2010-04-10       Impact factor: 9.776

Review 7.  Induction of anti-cancer T cell immunity by in situ vaccination using systemically administered nanomedicines.

Authors:  Geoffrey M Lynn; Richard Laga; Christopher M Jewell
Journal:  Cancer Lett       Date:  2019-06-08       Impact factor: 8.679

8.  Challenges and opportunities in the advancement of nanomedicines.

Authors:  Alexander Wei; Jonathan G Mehtala; Anil K Patri
Journal:  J Control Release       Date:  2012-10-12       Impact factor: 9.776

Review 9.  Nanotechnology in head and neck cancer: the race is on.

Authors:  Ivan H El-Sayed
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

10.  The cytotoxic effects of lipidic formulated gold porphyrin nanoparticles for the treatment of neuroblastoma.

Authors:  Puiyan Lee; Yifan Zhu; Jessie J Yan; Raymond Wy Sun; Wei Hao; Xuelai Liu; Chi-Ming Che; Kenneth Ky Wong
Journal:  Nanotechnol Sci Appl       Date:  2010-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.